Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP642037.RAAGc9xuQt4VJzmTB_50i--VI3TjBjb2_foIXQ2amoes4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP642037.RAAGc9xuQt4VJzmTB_50i--VI3TjBjb2_foIXQ2amoes4130_assertion type Assertion NP642037.RAAGc9xuQt4VJzmTB_50i--VI3TjBjb2_foIXQ2amoes4130_head.
- NP642037.RAAGc9xuQt4VJzmTB_50i--VI3TjBjb2_foIXQ2amoes4130_assertion description "[Although the oncogenic mechanism of TBC1D3 has yet to be elucidated, the TBC1D3 locus (chromosome 17q12) is amplified in 15% of primary prostate tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642037.RAAGc9xuQt4VJzmTB_50i--VI3TjBjb2_foIXQ2amoes4130_provenance.
- NP642037.RAAGc9xuQt4VJzmTB_50i--VI3TjBjb2_foIXQ2amoes4130_assertion evidence source_evidence_literature NP642037.RAAGc9xuQt4VJzmTB_50i--VI3TjBjb2_foIXQ2amoes4130_provenance.
- NP642037.RAAGc9xuQt4VJzmTB_50i--VI3TjBjb2_foIXQ2amoes4130_assertion SIO_000772 16863688 NP642037.RAAGc9xuQt4VJzmTB_50i--VI3TjBjb2_foIXQ2amoes4130_provenance.
- NP642037.RAAGc9xuQt4VJzmTB_50i--VI3TjBjb2_foIXQ2amoes4130_assertion wasDerivedFrom befree-20140225 NP642037.RAAGc9xuQt4VJzmTB_50i--VI3TjBjb2_foIXQ2amoes4130_provenance.
- NP642037.RAAGc9xuQt4VJzmTB_50i--VI3TjBjb2_foIXQ2amoes4130_assertion wasGeneratedBy ECO_0000203 NP642037.RAAGc9xuQt4VJzmTB_50i--VI3TjBjb2_foIXQ2amoes4130_provenance.